1-4 of 4
Chris A. Fisher
Close
Sort by
Journal Articles

Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait

Emma Jones, Sant-Rayn Pasricha, Angela Allen, Patricia Evans, Chris A. Fisher, Katherine Wray, Anuja Premawardhena, Dyananda Bandara, Ashok Perera, Craig Webster, Pamela Sturges, Nancy F. Olivieri, Timothy St. Pierre, Andrew E. Armitage, John B. Porter, David J. Weatherall, Hal Drakesmith
Journal: Blood
Blood (2015) 125 (5): 873–880.
https://doi.org/10.1182/blood-2014-10-606491
Published: 2015
Includes: Supplemental data
Journal Articles

Identification of a Gain-of-Function SNP Causing a New Model of α-Thalassaemia.

Marco De Gobbi, MD, Vip Viprakasit, MD, PhD, Pieter J. de Jong, PhD, Yuko Yoshinaga, PhD, Jan-Fang Cheng, PhD, Jim R. Hughes, PhD, Chris A. Fisher, PhD, William G. Wood, PhD, Donald K. Bowden, PhD, Douglas R. Higgs, MD
Journal: Blood
Blood (2005) 106 (11): 523.
https://doi.org/10.1182/blood.V106.11.523.523
Published: 2005
Journal Articles

A Novel Splicing Mutation in the Gene Encoding the Chromatin-Associated Factor ATRX Associated with Acquired Hemoglobin H Disease in Myelodysplastic Syndrome (ATMDS).

David P. Steensma, MD, Steven L. Allen, MD, Richard J. Gibbons, MA DPhil FRCP, Chris A. Fisher, DPhil, Douglas R. Higgs, DSc(Med) FRCP
Journal: Blood
Blood (2004) 104 (11): 3606.
https://doi.org/10.1182/blood.V104.11.3606.3606
Published: 2004
Journal Articles

Acquired somatic ATRX mutations in myelodysplastic syndrome associated with α thalassemia (ATMDS) convey a more severe hematologic phenotype than germline ATRX mutations

Clinical Trials & Observations
David P. Steensma, Douglas R. Higgs, Chris A. Fisher, Richard J. Gibbons
Journal: Blood
Blood (2004) 103 (6): 2019–2026.
https://doi.org/10.1182/blood-2003-09-3360
Published: 2004